Catherine Corrigan, who serves as President and Chief Executive Officer of Exponent Inc (NASDAQ:EXPO), completed the sale of 3,920 shares of the company's common stock on February 17, 2026. The transactions, carried out in two tranches, produced aggregate proceeds of approximately $263,239. Reported execution prices for those sales fell in a tight band from $67.1378 to $67.1646.
On the same trading day, Corrigan exercised stock options allowing her to acquire an additional 5,606 shares of Exponent common stock. Those option exercises were executed at strike prices of $25.405 and $29.05, and the combined value of those exercised options is reported at $151,095.
These insider moves coincided with the company's publication of fourth-quarter 2025 financial results. Exponent reported quarterly revenue of $147.4 million, representing an 8% increase versus the comparable quarter a year earlier. The company also posted earnings per share of $0.49, beating the consensus estimate of $0.4738.
Following the earnings release, Exponent experienced a slight decline in after-hours trading. Market reaction was modest, and commentary surrounding the results has emphasized the company's ability to exceed expectations on both top-line revenue and EPS for the quarter.
Context and emphasis
The sequence of events on February 17 - an insider sale paired with option exercises and the release of stronger-than-expected quarterly results - provides a concise snapshot of recent activity at Exponent. The facts reported include the exact share counts, price ranges, option strike prices, and the stated dollar values of both the sales and the exercised options, along with the audited quarterly revenue and earnings-per-share figures and the percentage change from the prior year.
Readers should note that the documentation of the sales, the option exercises, and the earnings results are presented as reported figures. The modest dip in after-hours trading following the announcement is recorded as part of the company's recent market activity.
Takeaway
- CEO Catherine Corrigan sold 3,920 shares for about $263,239 on February 17, 2026, at prices between $67.1378 and $67.1646.
- Corrigan also exercised options to obtain 5,606 shares at $25.405 and $29.05, with those exercises totaling $151,095 in value.
- Exponent reported Q4 2025 revenue of $147.4 million (up 8% year-over-year) and EPS of $0.49, above the $0.4738 forecast; after-hours trading fell slightly after the announcement.